nirsevimab

Noun

1. A human recombinant monoclonal antibody used to prevent respiratory syncytial virus (RSV) infections in infants.
   • There is another remedy under regulatory consideration, a monoclonal antibody shot developed by Sanofi and AstraZeneca, called nirsevimab. It is meant to be given at the hospital to babies who are born during the winter...